|Mr. David M. Stack||Chairman & CEO||1.5M||4.18M||1950|
|Mr. Charles A. Reinhart III, CPA, M.B.A.||Chief Financial Officer||644.22k||N/A||1961|
|Ms. Kristen Williams||Chief Admin. Officer & Sec.||732.61k||N/A||1974|
|Dr. Richard Scranton M.D., MPH||Chief Medical Officer||733.74k||N/A||1967|
|Mr. Dennis McLoughlin||Chief Commercial Officer||535.87k||N/A||1966|
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for health care practitioners and their patients in the United States. The company develops products based on its proprietary DepoFoam product delivery technology that encapsulates drugs without altering their molecular structure. It offers EXPAREL, a non-opioid medication administered at the time of surgery to control pain while reducing opioid requirements; and iovera system, a handheld cryoanalgesia device used to deliver controlled doses of cold temperature only to targeted nerves. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. has collaboration with Aetna. Pacira BioSciences, Inc. was founded in 2006 and is based in Parsippany, New Jersey.
Pacira BioSciences, Inc.’s ISS Governance QualityScore as of June 25, 2019 is 6. The pillar scores are Audit: 5; Board: 5; Shareholder Rights: 7; Compensation: 7.